CO 026: ALTERNATIVE METHODS AND THE SAFETY ASSESSMENT OF HEALTH PRODUCTS: EXPERIENCE OF NATIONAL INSTITUTE OF QUALITY CONTROL IN HEALTH, BRAZIL

Excerpt:


J Pharm Pharmacogn Res 2(Suppl. 1): S14, 2014 Special supplement with the abstract book of LATINFARMA 2013 Oral Communication CO 026: ALTERNATIVE METHODS AND THE SAFETY ASSESSMENT OF HEALTH PRODUCTS: EXPERIENCE OF NATIONAL INSTITUTE OF QUALITY CONTROL IN HEALTH, BRAZIL Fernandes Delgado I, Chaves Leal E. National Institute of Quality Control in Health (INCQS) - … Continue reading CO 026: ALTERNATIVE METHODS AND THE SAFETY ASSESSMENT OF HEALTH PRODUCTS: EXPERIENCE OF NATIONAL INSTITUTE OF QUALITY CONTROL IN HEALTH, BRAZIL

J Pharm Pharmacogn Res 2(Suppl. 1): S14, 2014

Special supplement with the abstract book of LATINFARMA 2013

Oral Communication

CO 026: ALTERNATIVE METHODS AND THE SAFETY ASSESSMENT OF HEALTH PRODUCTS: EXPERIENCE OF NATIONAL INSTITUTE OF QUALITY CONTROL IN HEALTH, BRAZIL

Fernandes Delgado I, Chaves Leal E.

National Institute of Quality Control in Health (INCQS) - Oswaldo Cruz Foundation (Fiocruz) – Av. Brasil, 4365 – Manguinhos - Rio de Janeiro - Brasil. www.incqs.fiocruz.br - E-mail: isabella.delgado@incqs.fiocruz.br
Abstract

The National Institute of Quality Control in Health (INCQS) is a technical-scientific unit of the Oswaldo Cruz Foundation (Fiocruz) and is the Brazilian Reference Laboratory which handles the quality control of food, drugs, biological products, health-related and dialysis items, hygienizing and disinfectant agents, diagnostic kits, cosmetics, blood and blood derivatives, environments and services. Its mission is to contribute to the promotion and recovery of health conditions, to the prevention of diseases, acting as the National Reference for scientific and technical issues regarding the quality control of products, environments and health services. Regarding safety assessment, our staff has been dealing with toxicological assays and also works to develop, adjust and implement new methodologies. In the field of alternative methods, some new approaches have been investigated, such as: (i.) alternatives to eye and skin irritation tests, including HETCAM, RBC and cytotoxicity assays, (ii.) alternatives to pyrogen test and (iii.) phototoxicity, as well as (iv.) in silico alternatives. Additionally, our staff has been working in strait collaboration with Brazilian Health Surveillance Agency (Anvisa) in order to consolidate activities of the newly created Brazilian Center for Validation of Alternative Methods (BraCVAM). By means of this initiative, it is aimed to achieve interlaboratory validation of alternative methodologies, seeking the regulatory acceptance.

Piceatannol-rich extract from Passiflora edulis and hyperpigmentation
J. Pharm. Pharmacogn. Res., vol. 12, no. 5, pp. 900-910, Sep-Oct 2024. DOI: https://doi.org/10.56499/jppres23.1717_12.5.900 Original Article Piceatannol-rich extract from Passiflora edulis Sims seeds attenuates morphological differentiation through the reduction of MITF mRNA expression and F-actin polymerization in UVB-induced hyperpigmented B16F10 cells [El extracto rico en piceatannol de las semillas de Passiflora edulis Sims atenúa la … Continue reading Piceatannol-rich extract from Passiflora edulis and hyperpigmentation
Immunostimulatory effect of a nature-derived capsule
J. Pharm. Pharmacogn. Res., vol. 12, no. 5, pp. 892-899, Sep-Oct 2024. DOI: https://doi.org/10.56499/jppres23.1751_12.5.892 Original Article Potential effects of Linh Loc Son hard capsule – a Vietnamese herbal combination in immunodeficiency induced by cyclophosphamide on mice [Efectos potenciales de la cápsula dura Linh Loc Son, una combinación de hierbas vietnamitas en la inmunodeficiencia inducida por … Continue reading Immunostimulatory effect of a nature-derived capsule
Epidermal growth factor receptor mutant inhibitors as NSCLC drugs
J. Pharm. Pharmacogn. Res., vol. 12, no. 5, pp. 881-891, Sep-Oct 2024. DOI: https://doi.org/10.56499/jppres23.1740_12.5.881 Original Article Epidermal growth factor receptor mutant T790M-L858R-V948R inhibitor from Calophyllum inophyllum L. leaf as potential non-small cell lung cancer drugs [Inhibidor del receptor del factor de crecimiento epidérmico mutante T790M-L858R-V948R de la hoja de Calophyllum inophyllum L. como posible fármaco … Continue reading Epidermal growth factor receptor mutant inhibitors as NSCLC drugs

© 2013-2020 by the authors; licensee JPPRes, Antofagasta, Chile. This journal is an open-access journal distributed under the terms and conditions of the Creative Commons Attribution license-Non Commercial 4.0 international. The content on this site is intended for health professionals. If you are not a health professional, please talk to your doctor about any doubts or concerns regarding your health

Made with ♥ by AVAGAX Studio